Neuromyelitis Optica Spectrum Disorder research hub
4 indexed studies · 4 currently recruiting
- recruitingPHASE2
Study of Inebilizumab in Pediatric Subjects With Neuromyelitis Optica Spectrum Disorder
This study is looking at a new medicine called inebilizumab for children and teenagers aged 2-17 with a rare condition called Neuromyelitis Optica Spectrum Disorder (NMOSD). It will check how the medicine works, how safe it is, and what effects it has on the body.
United States · Argentina · Brazil - recruitingPHASE3
A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)
This study is looking at a new medicine called Satralizumab for children aged 2-11 with a rare condition called Neuromyelitis Optica Spectrum Disorder (NMOSD). It will primarily check how the medicine moves through the body, with a broad look at how well it works and if it's safe.
United States · Argentina · China - recruiting
Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies
This study looks at how well Alexion C5 inhibitor medicines work for people with a specific type of Neuromyelitis Optica Spectrum Disorder (NMOSD). It collects information over time to see how patients' health and quality of life are affected by these treatments in the real world.
United States · Argentina · Canada - not yet recruiting
Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool
This study looks at how your genes and health information after optic neuritis might help predict if you'll develop multiple sclerosis (MS). It also checks your vision and quality of life.
United Kingdom